Anzeige
Erschienen in:
27.10.2022 | Clinical Investigation
Treatment of recurrent high myopic macular hole associated with retinal detachment using a human amniotic membrane
Erschienen in: Japanese Journal of Ophthalmology | Ausgabe 6/2022
Einloggen, um Zugang zu erhaltenAbstract
Purpose
To determine the efficacy of using a human amniotic membrane to close macular hole retinal detachment in highly myopic eyes.
Study design
Prospective, consecutive, nonrandomized interventional study.
Methods
We included 19 high myopic eyes from 19 patients affected by macular hole retinal detachment who had already undergone vitrectomy with internal limiting membrane peeling. The patients underwent vitrectomy with amniotic membrane transplant.
Results
Primary success was achieved after 3 months in 89.5% (17 of 19 eyes) and final macular hole closure was obtained in 94.7% (18 of 19 eyes) of the patients. The final retinal reattachment rate was 100%. The final 12-month mean BCVA improved from 20/2000 (2 logMAR) to 20/250 (1.1 logMAR). OCT-angiography revealed a high correlation between the superficial and deep capillary plexus and the final BCVA.
Conclusion
Human amniotic membrane patches can effectively repair macular hole retinal detachment in high myopic eyes in terms of anatomic results and BCVA recovery.